RACE IMPACT ON DOLUTEGRAVIR-ASSOCIATED WEIGHT GAIN AMONG PREVIOUSLY ART-NAIVE PLWH
Initiation of dolutegravir (DTG)-based antiretroviral therapy (ART) has been associated with weight gain in some people living with HIV (PLWH), and race has been proposed as a risk factor. Prior studies have mixed naïve and treated PLWH or used historic regimen comparisons complicating interpretation. Therefore, we examined the role of race in substantial weight gain…